Low Dose Aspirin for the Prevention of Preeclampsia
Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over
the world. The use of low dose aspirin has been mentioned in several studies with promising
results. The investigators decided to evaluate the use of low dose aspirin, starting between
13 and 16 weeks of pregnancy, based on clinical characteristics only to reduce the incidence
of preeclampsia.